Arctigenin: Harnessing Nature’s Power as an Anti-Inflammatory Agent

Inflammation is a crucial response to injury and infection, but when it becomes chronic, it can contribute to various diseases such as arthritis, cardiovascular issues, and neurodegenerative disorders. Traditional anti-inflammatory drugs like NSAIDs and corticosteroids effectively alleviate symptoms but often come with significant side effects, including gastrointestinal, cardiovascular, and renal complications. This has sparked growing interest in natural anti-inflammatory agents derived from plants, known for their potential to mitigate these adverse effects. Bioactive compounds found in plants, including flavonoids, terpenoids, and alkaloids, have demonstrated promising anti-inflammatory properties. Arctigenin, a bioactive lignan present in several plants, has attracted attention due to its potent anti-inflammatory effects. Arctigenin works by influencing critical inflammatory pathways, such as inhibiting NF-κB activation, reducing pro-inflammatory cytokines, and counteracting oxidative stress. Its mechanism involves suppressing inflammatory mediators and enzymes like COX-2 and iNOS. Additionally, arctigenin blocks the MAPK and PI3K/ Akt signaling pathways, underscoring its potential therapeutic value. In addition, arctigenin shows promise as a candidate for drug development due to its multifaceted anti-inflammatory mechanisms and limited side effects. However, extensive follow-up studies, including clinical trials and pharmacokinetic evaluations, are necessary to fully understand its therapeutic potential, safety profile, and effectiveness in human use.